UBS/CALL/DOCMORRIS/80.005/0.02/20.12.24 Stock

UBS/CALL/DOCMORRIS/80.005/0.02/20.12.24 Share Price

DOCBEU

CH1315872692

Market Closed - Bid/Ask 16:20:00 27/06/2024 BST			After market 16:15:00
0.08 ^CHF	-11.11%		0.07	-12.50%

3 months

-80.95%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DOCMORRIS AG

Chart UBS/CALL/DOCMORRIS/80.005/0.02/20.12.24

Latest news about DOCMORRIS AG

DOCMORRIS : Gets a Buy rating from Jefferies	06-19	ZD
DOCMORRIS : Jefferies gives a Buy rating	06-05	ZD
DOCMORRIS : Receives a Sell rating from UBS	06-04	ZD
DocMorris : AGM Minutes 2024	05-30	PU

More news

Quotes 5-day view

Date	Price	Change
27/06/24	0.08	-11.11%

Delayed Quote Swiss Exchange

Last update June 27, 2024 at 04:20 pm

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	DOCMORRIS AG
Issuer	UBS
	DOCBEU
ISIN	CH1315872692
Date issued	10/01/2024
Strike	80 CHF
Maturity	20/12/2024 (172 Days)
Parity	50 : 1
Emission price	0.43 CHF
Emission volume	N/A
Settlement	Por entregas
Currency	CHF

Technical Indicators

Highest since issue	0.66 CHF
Lowest since issue	0.08 CHF
Delta	0.28x
Omega	4.164
Premium	58.45x
Gearing	15.06x
Moneyness	0.6587
Difference Strike	27.3 CHF
Difference Strike %	+34.13%
Spread	0.02 CHF
Spread %	25.00%
Theoretical value	0.0700
Implied Volatility	71.40 %
Total Loss Probability	86.06 %
Intrinsic value	0.000000
Present value	0.0700
Break even	83.51 CHF
Theta	-0x
Vega	0x
Rho	0x

Company Profile

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Sector

More about the company

Ratings for DocMorris AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DocMorris AG

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

53.5 CHF

Average target price

98.58 CHF

Spread / Average Target

+84.27%

Consensus